Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials |
| BNF code | 0501014S0AAABAB |
| Virtual Therapeutic Moiety | Piperacillin + Tazobactam |
| Date identifier became valid | 9 Jun 2023 |
| Previous product identifier | 323671007 |
| Abbreviated name | Piperacillin 4g / Tazobactam 500mg inf vials |
| Basis of preferred name | Other |
| Date of name applicability | 27 Jul 2017 |
| Previous name | Piperacillin 4g / Tazobactam 500mg powder for solution for injection vials |
| Basis of previous name | Other |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Piperacillin sodium |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372836004 |
| Strength value numerator | 4.000 |
| Strength value numerator unit | gram |
| Virtual Product Ingredient | |
| Ingredient | Tazobactam sodium |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 96007008 |
| Strength value numerator | 500.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solutioninfusion.intravenous |
| Dose Form | |
| Formulation | Powder for solution for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Bowmed Ibisqus Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Esteve Pharmaceuticals Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Milpharm Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Reig Jofre UK Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Sandoz Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Tillomed Laboratories Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Viatris UK Healthcare Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Wockhardt UK Ltd) | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) | |
| Tazocin 4g/0.5g powder for solution for infusion vials (Pfizer Ltd) | |
| Virtual Medicinal Product Packs | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials 10 vial | |
| Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.